FIELD: chemistry.
SUBSTANCE: invention relates to novel pyridin-2-one and pyridazin-3-one derivatives, having Btk inhibiting activity. In formulae I-IV:
,
R denotes -R1-R2-R3 or -R2-R3; R1 denotes a heteroaryl containing 6 ring atoms, including one N heteroatom; R2 denotes -C(=O), -C(=O)N(R2'), where R2' denotes H; R3 denotes R4; where R4 is a lower alkyl, heterocycloalkyl, (lower alkyl) heterocycloalkyl or heterocycloalkyl (lower alkyl), where the heterocycloalkyl contains 6 ring atoms, including two heteroatoms selected from N and O; and where R4 can be substituted with one or more substitutes selected from lower alkyl, oxo group and lower alkoxy group; X denotes CH or N; Y1 denotes lower alkyl; n and m are equal to 0; values of radicals Y2, Y4 are given in the claim.
EFFECT: improved properties of compounds.
6 cl, 2 tbl, 42 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL PHENYLPYRAZINONES AS KINASE INHIBITORS | 2009 |
|
RU2507202C2 |
BRUTON'S TYROSINE KINASE INHIBITORS | 2010 |
|
RU2542585C2 |
NOVEL PYRIDINONES AND PYRIDAZINONES | 2009 |
|
RU2505538C2 |
USING EP4 RECEPTOR ANTAGONISTS IN TREATING IL-23-MEDIATED DISEASES | 2011 |
|
RU2571816C2 |
JNK INHIBITORS | 2009 |
|
RU2504545C2 |
USE OF EP4 RECEPTOR ANTAGONIST IN TREATMENT OF CARTILAGE DISEASE | 2014 |
|
RU2663620C2 |
NOVEL ANTICONVULSIVE SUBSTITUTED SULFAMATE DERIVATIVES | 2003 |
|
RU2328502C2 |
THIAZOLYL DIHYDROQUINAZOLINES | 2007 |
|
RU2430923C2 |
TETRAHYDROBENZIMIDAZOLE DERIVATIVES AS TNF ACTIVITY MODULATORS | 2014 |
|
RU2684637C1 |
IMIDAZOTRIAZINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2677699C1 |
Authors
Dates
2013-12-10—Published
2009-06-15—Filed